To investigate the effects of TAM depletion on tumor growth under conditions of obesity, we randomized lean and obese mice into treatment groups receiving either anti-F4/80 antibodies to deplete macrophages or IgG control antibodies and transplanted Met-1 tumor cells into mammary fat pads. Here, GZMM is linked to obesity due to melanocortin 4 receptor deficiency.